Biotech · Private company · Los Angeles, CA, US
Sensydia Corporation
Track this companyFree. Adds Sensydia Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Cardiac Performance System (CPS)Cardiovascular DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- Cardiac Performance System (NSR)Cardiac DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Pivotal Study for the Cardiac Performance System (CPS)RECRUITING · started Apr 22, 2025ClinicalTrials.gov NCT06870591 · fetched Nov 12, 2026
- Cardiac Performance System Data Collection Study - MinnesotaUNKNOWN · started Oct 3, 2023ClinicalTrials.gov NCT06149143 · fetched Nov 12, 2026
- Cardiac Performance System Data Collection StudyUNKNOWN · started May 30, 2023ClinicalTrials.gov NCT05866666 · fetched Nov 12, 2026
- Echocardiogram and Cardiac Performance System (CPS) Ejection Fraction Validation StudyCOMPLETED · started Nov 9, 2021ClinicalTrials.gov NCT05104307 · fetched Nov 12, 2026
- Cardiac Function Non-Invasive Monitoring System Evaluation TrialCOMPLETED · started Nov 9, 2020ClinicalTrials.gov NCT04131725 · fetched Nov 12, 2026
NIH awards2
- A non-invasive, automated platform for hemodynamic assessment of patients at risk of heart failure or pulmonary hypertensionFiscal year 2026 · $816.1KNIH RePORTER 5R42HL167342-03 · fetched Nov 12, 2026
- A non-invasive, automated platform for hemodynamic assessment of patients at risk of heart failure or pulmonary hypertensionFiscal year 2025 · $1.6MNIH RePORTER 4R42HL167342-02 · fetched Nov 12, 2026